My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Natera, Inc. - Common Stock (NQ:NTRA)

237.69 +2.84 (+1.21%)

Streaming Delayed Price Updated: 11:17 AM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Natera, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 09, 2024

Via Benzinga

How Is The Market Feeling About Natera? ↗

May 09, 2024

Via Benzinga

Looking Into Natera's Recent Short Interest ↗

April 23, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Natera ↗

April 05, 2024

Via Benzinga

Looking Into Natera's Recent Short Interest ↗

April 05, 2024

Via Benzinga

Disney, Natera, Chubb And A Major Tech Stock On CNBC's 'Final Trades' ↗

March 12, 2024

On CNBC’s "Halftime Report Final Trades," Amy Raskin of Chevy Chase Trust said Natera, Inc.

Via Benzinga

Recap: Natera Q4 Earnings ↗

February 28, 2024

Via Benzinga

Earnings Preview For Natera ↗

February 27, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Natera Through 9 Analysts ↗

February 20, 2024

Via Benzinga

There are signs that NASDAQ:NTRA may be ready to breakout. ↗

February 16, 2024

NATERA INC (NASDAQ:NTRA) has a good technical rating of 10 out of 10 and could possibly break out.

Via Chartmill

9 Health Care Stocks Whale Activity In Today's Session ↗

March 08, 2024

Via Benzinga

Agilent Technologies Stock Getting Closer To Key Technical Benchmark ↗

March 05, 2024

Agilent Technologies stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 65 to 71.

Via Investor's Business Daily

Wall Street Takes A Breather As Inflation Stays Tamed, AMD Hits Record Highs, Apple Struggles: What's Driving Markets Thursday? ↗

February 29, 2024

Wall Street exhaled a sigh of relief as the Federal Reserve’s favored gauge of inflation cooled as anticipated in January, quelling fears that an unexpected rise in the Consumer Price Index (CPI) might...

Via Benzinga

Topics Economy

Expert Ratings For Natera ↗

January 17, 2024

Via Benzinga

The Analyst Landscape: 8 Takes On Natera ↗

December 29, 2023

Via Benzinga

The Latest Analyst Ratings for Natera ↗

December 12, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 28, 2024

Via Benzinga

Earnings Scheduled For February 28, 2024 ↗

February 28, 2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.

Via Benzinga

Cathie Wood's Ark Invest Sheds $9.3M Worth Of Coinbase Shares Amid Bitcoin Rally — Robinhood Stock Also Sold ↗

February 27, 2024

On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades.

Via Benzinga

3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List ↗

February 06, 2024

These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry.

Via InvestorPlace

NVTA Stock: Invitae Plunges 78% on the Brink of Bankruptcy ↗

February 06, 2024

NVTA stock tumbled yesterday amid a report that the firm could declare bankruptcy soon. The shares were halted for news pending.

Via InvestorPlace

Topics Bankruptcy

SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy ↗

February 05, 2024

Invitae's financial challenges as it grapples with a $1.5 billion debt burden. Explore the company's strategic options amidst potential bankruptcy, asset shedding, and cost-cutting measures.

Via Benzinga

Topics Bankruptcy

Pinterest, Checkpoint Therapeutics And 2 Other Stocks Insiders Are Selling ↗

February 05, 2024

The Nasdaq 100 closed higher by around 300 points on Friday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle ↗

January 17, 2024

The company must pay $57 million in damages, but that's far less than expected.

Via Investor's Business Daily

Topics Intellectual Property

Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket ↗

January 17, 2024

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market...

Via Benzinga

Progress Software Posts Strong Q4 Results, Joins Impinj, REGENXBIO And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

January 17, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling more than 100 points on Wednesday. Shares of Progress Software Corporation (NASDAQ: PRGS) rose in pre-market trading as...

Via Benzinga

Topics Stocks

Bull of the Day - NeoGenomics ↗

January 12, 2024

But in late December, shares took a big hit on patent litigation with competitor Natera. Let's review the primary commercial business of NEO and then that will help put the legal news into context.

Via Talk Markets

Topics Intellectual Property

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

December 29, 2023

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.

Via Benzinga

Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday ↗

December 29, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit ↗

December 28, 2023

Shares of NeoGenomics Inc (NASDAQ: NEO) fell Thursday after the company received a preliminary injunction from a North Carolina district court, which prohibits the company from

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.